Wednesday, November 30, 2016

Top 10 Up And Coming Companies To Own In Right Now

Top 10 Up And Coming Companies To Own In Right Now: Activision Blizzard, Inc(ATVI)

Advisors' Opinion:
  • [By Manikandan Raman]

    Gameloft said it will issue a statement after the board meeting, which has been convened for next week. Until then, no further comments will be made regarding this unsolicited bid. Both Gameloft and Ubisoft compete with Activision Blizzard, Inc. (NASDAQ: ATVI) and Electronic Arts Inc. (NASDAQ: EA).

  • [By Javier Hasse]

    The top losers in the index were:

    Activision Blizzard, Inc. (NASDAQ: ATVI), down 7.86 percent Tripadvisor Inc (NASDAQ: TRIP), down 1.92 percent

    Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

  • source from Top Stocks For 2015:http://www.topstocksblog.com/top-10-up-and-coming-companies-to-own-in-right-now-3.html

Monday, November 28, 2016

Hot Building Product Stocks For 2017

Will you have to support your kids after they graduate from college?

As anyone who has a child in college knows, this is a scary time to be a twenty-something. A recent study by the Economic Policy Institute found that the unemployment rate for young college grads is still 7.2% (it was 5.5% in 2007) and the underemployment rate is almost 15% (9.6% in 2007). Underemployment could mean working at a job below your skill level or working part-time because full-time positions aren't available.

See Also: 10 Best Jobs for the Future

Does that mean your college grad is on the fast track to move back home?

As much as my wife and I would love to have a full nest again, I don't think it's generally a good long-term solution��for anybody. With so many parents' retirement plans under pressure already, the impact of supporting an adult child for a long period of time could be burdensome. On the young adult's side, relying on parents for too long can lead to a case of arrested development.

Hot Building Product Stocks For 2017: NewJersey Resources Corporation(NJR)

Advisors' Opinion:
  • [By Daniela Pylypczak]

    New Jersey Resources Corp.(NJR) announced on Tuesday that it will raise its quarterly dividend rate by 5%.

    The new quarterly dividend rate will be 42 cents per share, up 2 cents from the prior 40 cents per share rate. Annually, the dividend rate will now be $1.68 per share. The new rate will be effective with the dividend payable October 1, 2013 to shareholders of record on September 23, 2013.

    Commenting on the increase, Chairman and CEO Laurence M. Downes noted “Our shareowners look to us year after year for consistent financial performance and a competitive return on their investment.�he action taken today by our board of directors allows us to increase our dividend for the 20th time in the last 18 years. This is an acknowledgement of our team’s unwavering focus to provide exceptional value for our customers and shareowners.”

    New Jersey Resources shares traded 0.06% lower during Tuesday’s session. Year-to-date, the stock is up 5.90%.

Hot Building Product Stocks For 2017: Xenon Pharmaceuticals Inc.(XENE)

Advisors' Opinion:
  • [By Jim Robertson]

    Yesterday, our Under the Radar Movers�newsletter suggested going long on small cap biopharmaceutical stock Xenon Pharmaceuticals Inc (NASDAQ: XENE):

Hot Building Product Stocks For 2017: Teva Pharmaceutical Industries Limited(TEVA)

Advisors' Opinion:
  • [By Paul Ausick]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) dropped about 1.1% on Friday to post a new 52-week low of $45.76 against a 52-week high of $66.55. Volume of nearly 11 million was around double the daily average of 6 million shares traded. The stock closed at $46.29 on Thursday night. The drug maker had no specific news Friday.

  • [By Ben Levisohn]

    Shares of Endo International (ENDP) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink’s Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models–and find Akorn (AKRX), Perrigo (PRGO), and Teva Pharmaceutical Industries (TEVA). They explain:

  • [By Ben Levisohn]

    Johnson & Johnson (JNJ) now has a market cap of $308 billion dollars, just a smidgen less than that of Gilead Sciences (GILD), Biogen (BIIB), Mylan (MYL), Celgene (CELG) and Teva Pharmaceutical Industries (TEVA) combined. It’s time to sell, says Standpoint Research’s Ronnie Moas: